A proximity-labeling proteomic approach to investigate invadopodia molecular landscape in breast cancer cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 04 2020
Historique:
received: 02 12 2019
accepted: 06 04 2020
entrez: 24 4 2020
pubmed: 24 4 2020
medline: 1 12 2020
Statut: epublish

Résumé

Metastatic progression is the leading cause of mortality in breast cancer. Invasive tumor cells develop invadopodia to travel through basement membranes and the interstitial matrix. Substantial efforts have been made to characterize invadopodia molecular composition. However, their full molecular identity is still missing due to the difficulty in isolating them. To fill this gap, we developed a non-hypothesis driven proteomic approach based on the BioID proximity biotinylation technology, using the invadopodia-specific protein Tks5α fused to the promiscuous biotin ligase BirA* as bait. In invasive breast cancer cells, Tks5α fusion concentrated to invadopodia and selectively biotinylated invadopodia components, in contrast to a fusion which lacked the membrane-targeting PX domain (Tks5β). Biotinylated proteins were isolated by affinity capture and identified by mass spectrometry. We identified known invadopodia components, revealing the pertinence of our strategy. Furthermore, we observed that Tks5 newly identified close neighbors belonged to a biologically relevant network centered on actin cytoskeleton organization. Analysis of Tks5β interactome demonstrated that some partners bound Tks5 before its recruitment to invadopodia. Thus, the present strategy allowed us to identify novel Tks5 partners that were not identified by traditional approaches and could help get a more comprehensive picture of invadopodia molecular landscape.

Identifiants

pubmed: 32321993
doi: 10.1038/s41598-020-63926-4
pii: 10.1038/s41598-020-63926-4
pmc: PMC7176661
doi:

Substances chimiques

Adaptor Proteins, Vesicular Transport 0
Escherichia coli Proteins 0
Recombinant Fusion Proteins 0
Repressor Proteins 0
SH3PXD2A protein, human 0
Carbon-Nitrogen Ligases EC 6.3.-
birA protein, E coli EC 6.3.4.15

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6787

Références

Eddy, R. J., Weidmann, M. D., Sharma, V. P. & Condeelis, J. S. Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis. Trends Cell Biol. 27, 595–607 (2017).
pubmed: 28412099 pmcid: 5524604 doi: 10.1016/j.tcb.2017.03.003
Linder, S., Wiesner, C. & Himmel, M. Degrading devices: invadosomes in proteolytic cell invasion. Annu. Rev. Cell Dev. Biol. 27, 185–211 (2011).
pubmed: 21801014 doi: 10.1146/annurev-cellbio-092910-154216
Weaver, A. M. Invadopodia: Specialized Cell Structures for Cancer Invasion. Clin. Exp. Metastasis 23, 97–105 (2006).
pubmed: 16830222 doi: 10.1007/s10585-006-9014-1
Meirson, T. & Gil-Henn, H. Targeting invadopodia for blocking breast cancer metastasis. Drug Resist. Updat. 39, 1–17 (2018).
pubmed: 30075834 doi: 10.1016/j.drup.2018.05.002
Paterson, E. K. & Courtneidge, S. A. Invadosomes are coming: new insights into function and disease relevance. FEBS J. 285, 8–27 (2018).
pubmed: 28548369 doi: 10.1111/febs.14123
Beaty, B. T. & Condeelis, J. Digging a little deeper: The stages of invadopodium formation and maturation. Eur. J. Cell Biol. 93, 438–444 (2014).
pubmed: 25113547 pmcid: 4262566 doi: 10.1016/j.ejcb.2014.07.003
Murphy, D. A. & Courtneidge, S. A. The ‘ins’ and ‘outs’ of podosomes and invadopodia: characteristics, formation and function. Nat. Rev. Mol. Cell Biol. 12, 413–426 (2011).
pubmed: 21697900 pmcid: 3423958 doi: 10.1038/nrm3141
Havrylov, S. & Park, M. MS/MS-based strategies for proteomic profiling of invasive cell structures. Proteomics 15, 272–286 (2015).
pubmed: 25303514 doi: 10.1002/pmic.201400220
Roux, K. J., Kim, D. I., Raida, M. & Burke, B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J. Cell Biol. 196, 801–810 (2012).
pubmed: 22412018 pmcid: 3308701 doi: 10.1083/jcb.201112098
Gingras, A.-C., Abe, K. T. & Raught, B. Getting to know the neighborhood: using proximity-dependent biotinylation to characterize protein complexes and map organelles. Curr. Opin. Chem. Biol. 48, 44–54 (2019).
pubmed: 30458335 doi: 10.1016/j.cbpa.2018.10.017
Kim, D. I. & Roux, K. J. Filling the Void: Proximity-Based Labeling of Proteins in Living Cells. Trends Cell Biol. 26, 804–817 (2016).
pubmed: 27667171 pmcid: 5077660 doi: 10.1016/j.tcb.2016.09.004
Saini, P. & Courtneidge, S. A. Tks adaptor proteins at a glance. J Cell Sci 131, jcs203661 (2018).
pubmed: 29311151 pmcid: 5818055 doi: 10.1242/jcs.203661
Seals, D. F. et al. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 7, 155–165 (2005).
pubmed: 15710328 doi: 10.1016/j.ccr.2005.01.006
Cejudo-Martin, P. et al. Genetic disruption of the sh3pxd2a gene reveals an essential role in mouse development and the existence of a novel isoform of tks5. PloS One 9, e107674 (2014).
pubmed: 25259869 pmcid: 4178035 doi: 10.1371/journal.pone.0107674
Li, C. M.-C. et al. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma. Genes Dev. 27, 1557–1567 (2013).
pubmed: 23873940 pmcid: 3731545 doi: 10.1101/gad.222745.113
Lock, P., Abram, C. L., Gibson, T. & Courtneidge, S. A. A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate. EMBO J. 17, 4346–4357 (1998).
pubmed: 9687503 pmcid: 1170768 doi: 10.1093/emboj/17.15.4346
Blouw, B. et al. The invadopodia scaffold protein Tks5 is required for the growth of human breast cancer cells in vitro and in vivo. PloS One 10, e0121003 (2015).
pubmed: 25826475 pmcid: 4380437 doi: 10.1371/journal.pone.0121003
Burger, K. L. et al. Src-Dependent Tks5 Phosphorylation Regulates Invadopodia-Associated Invasionin Prostate Cancer Cells. The Prostate 74, 134–148 (2014).
pubmed: 24174371 doi: 10.1002/pros.22735
Iizuka, S., Abdullah, C., Buschman, M. D., Diaz, B. & Courtneidge, S. A. The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma. Oncotarget 7, 78473–78486 (2016).
pubmed: 27802184 pmcid: 5346654 doi: 10.18632/oncotarget.12954
Stylli, S. S., I, S. T. T., Kaye, A. H. & Lock, P. Prognostic significance of Tks5 expression in gliomas. J. Clin. Neurosci. 19, 436–442 (2012).
pubmed: 22249020 doi: 10.1016/j.jocn.2011.11.013
Oikawa, T., Itoh, T. & Takenawa, T. Sequential signals toward podosome formation in NIH-src cells. J. Cell Biol. 182, 157–169 (2008).
pubmed: 18606851 pmcid: 2447888 doi: 10.1083/jcb.200801042
Abram, C. L. et al. The Adaptor Protein Fish Associates with Members of the ADAMs Family and Localizes to Podosomes of Src-transformed Cells. J. Biol. Chem. 278, 16844–16851 (2003).
pubmed: 12615925 doi: 10.1074/jbc.M300267200
Jacob, A., Linklater, E., Bayless, B. A., Lyons, T. & Prekeris, R. The role and regulation of Rab40b–Tks5 complex during invadopodia formation and cancer cell invasion. J. Cell Sci. 129, 4341–4353 (2016).
pubmed: 27789576 pmcid: 5201011 doi: 10.1242/jcs.193904
Diaz, B. et al. Tks5-Dependent, Nox-Mediated Generation of Reactive Oxygen Species Is Necessary for Invadopodia Formation. Sci. Signal. 2, ra53–ra53 (2009).
pubmed: 19755709 pmcid: 2810640 doi: 10.1126/scisignal.2000368
Stylli, S. S. et al. Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation. J. Cell Sci. 122, 2727–2740 (2009).
pubmed: 19596797 pmcid: 2909319 doi: 10.1242/jcs.046680
Oser, M., Dovas, A., Cox, D. & Condeelis, J. Nck1 and Grb2 localization patterns can distinguish invadopodia from podosomes. Eur. J. Cell Biol. 90, 181–188 (2011).
pubmed: 20850195 doi: 10.1016/j.ejcb.2010.08.006
Jeannot, P. & Besson, A. Cortactin function in invadopodia. Small GTPases 1–15. https://doi.org/10.1080/21541248.2017.1405773 (2017).
Ayala, I. et al. Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer. Cancer Res. 69, 747–752 (2009).
pubmed: 19141649 doi: 10.1158/0008-5472.CAN-08-1980
Daubon, T., Buccione, R. & Génot, E. The Aarskog-Scott syndrome protein Fgd1 regulates podosome formation and extracellular matrix remodeling in transforming growth factor β-stimulated aortic endothelial cells. Mol. Cell. Biol. 31, 4430–4441 (2011).
pubmed: 21911474 pmcid: 3209245 doi: 10.1128/MCB.05474-11
Tsuboi, S. et al. FBP17 Mediates a Common Molecular Step in the Formation of Podosomes and Phagocytic Cups in Macrophages. J. Biol. Chem. 284, 8548–8556 (2009).
pubmed: 19155218 pmcid: 2659213 doi: 10.1074/jbc.M805638200
Yamamoto, H. et al. Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells. J. Urol. 185, 1930–1938 (2011).
pubmed: 21421245 doi: 10.1016/j.juro.2010.12.027 pmcid: 21421245
Suman, P., Mishra, S. & Chander, H. High expression of FBP17 in invasive breast cancer cells promotes invadopodia formation. Med. Oncol. Northwood Lond. Engl. 35, 71 (2018).
doi: 10.1007/s12032-018-1132-5
Carmona, G. et al. Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE. Oncogene 35, 5155–5169 (2016).
pubmed: 26996666 pmcid: 5031503 doi: 10.1038/onc.2016.47
Boateng, L. R., Cortesio, C. L. & Huttenlocher, A. Src-mediated phosphorylation of mammalian Abp1 (DBNL) regulates podosome rosette formation in transformed fibroblasts. J. Cell Sci. 125, 1329–1341 (2012).
pubmed: 22303001 pmcid: 3324585 doi: 10.1242/jcs.096529
Dekky, B., Ruff, M., Bonnier, D., Legagneux, V. & Théret, N. Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures. Oncotarget 9, 21366–21382 (2018).
pubmed: 29765546 pmcid: 5940405 doi: 10.18632/oncotarget.25106
Kremerskothen, J. et al. Zona occludens proteins modulate podosome formation and function. FASEB J. 25, 505–514 (2011).
pubmed: 20930113 doi: 10.1096/fj.10-155598
Zhong, J. L. et al. Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Mol. Cancer Res. MCR 6, 383–394 (2008).
pubmed: 18296648 doi: 10.1158/1541-7786.MCR-07-2028
Albrechtsen, R., Stautz, D., Sanjay, A., Kveiborg, M. & Wewer, U. M. Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity. Exp. Cell Res. 317, 195–209 (2011).
pubmed: 20951132 doi: 10.1016/j.yexcr.2010.10.003
Eckert, M. A. et al. ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions. J. Cell Sci. 130, 2036–2048 (2017).
pubmed: 28468988 pmcid: 5482979 doi: 10.1242/jcs.198200
Kim, H.-Y., Ha Thi, H. T. & Hong, S. IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor. Cancer Lett. 415, 30–39 (2018).
pubmed: 29217458 doi: 10.1016/j.canlet.2017.11.039
Vikesaa, J. et al. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J. 25, 1456–1468 (2006).
pubmed: 16541107 pmcid: 1440323 doi: 10.1038/sj.emboj.7601039
Ben-Chetrit, N. et al. Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer. Sci. Signal. 8, ra7 (2015).
pubmed: 25605973 doi: 10.1126/scisignal.2005537
Chuang, Y.-Y. et al. Role of synaptojanin 2 in glioma cell migration and invasion. Cancer Res. 64, 8271–8275 (2004).
pubmed: 15548694 doi: 10.1158/0008-5472.CAN-04-2097
Nam, J.-M. et al. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J. 26, 647–656 (2007).
pubmed: 17255943 pmcid: 1794391 doi: 10.1038/sj.emboj.7601534
Schanda, K. et al. Nogo-B is associated with cytoskeletal structures in human monocyte-derived macrophages. BMC Res. Notes 4, 6 (2011).
pubmed: 21235733 pmcid: 3029212 doi: 10.1186/1756-0500-4-6
Rodríguez-Feo, J. A., Gallego-Delgado, J., Puerto, M., Wandosell, F. & Osende, J. Reticulon-4B/Nogo-B acts as a molecular linker between microtubules and actin cytoskeleton in vascular smooth muscle cells. Biochim. Biophys. Acta 1863, 1985–1995 (2016).
pubmed: 27132996 doi: 10.1016/j.bbamcr.2016.04.025
Vallenius, T. et al. The PDZ-LIM protein RIL modulates actin stress fiber turnover and enhances the association of alpha-actinin with F-actin. Exp. Cell Res. 293, 117–128 (2004).
pubmed: 14729062 doi: 10.1016/j.yexcr.2003.09.004
Vanaja, D. K. et al. PDLIM4, an actin binding protein, suppresses prostate cancer cell growth. Cancer Invest. 27, 264–272 (2009).
pubmed: 19212833 pmcid: 3086358 doi: 10.1080/07357900802406319
Rosslenbroich, V. et al. Collapsin response mediator protein-4 regulates F-actin bundling. Exp. Cell Res. 310, 434–444 (2005).
pubmed: 16181627 doi: 10.1016/j.yexcr.2005.08.005
Dang, I. et al. Inhibitory signalling to the Arp2/3 complex steers cell migration. Nature 503, 281–284 (2013).
pubmed: 24132237 doi: 10.1038/nature12611
Wilson, A. L., Schrecengost, R. S., Guerrero, M. S., Thomas, K. S. & Bouton, A. H. Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells. PloS One 8, e65678 (2013).
pubmed: 23762409 pmcid: 3675087 doi: 10.1371/journal.pone.0065678
Cai, D. et al. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cancer Res. 63, 6802–6808 (2003).
pubmed: 14583477
Bauer, K. et al. Human CLP36, a PDZ-domain and LIM-domain protein, binds to alpha-actinin-1 and associates with actin filaments and stress fibers in activated platelets and endothelial cells. Blood 96, 4236–4245 (2000).
pubmed: 11110697 doi: 10.1182/blood.V96.13.4236
Liu, Z. et al. PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with α-actinin. Oncogene 34, 1300–1311 (2015).
pubmed: 24662836 doi: 10.1038/onc.2014.64
Masi, G. et al. p66Shc regulates vesicle-mediated secretion in mast cells by affecting F-actin dynamics. J. Leukoc. Biol. 95, 285–292 (2014).
pubmed: 24078705 doi: 10.1189/jlb.0313178
Lin, Y.-H. et al. LIMCH1 regulates nonmuscle myosin-II activity and suppresses cell migration. Mol. Biol. Cell 28, 1054–1065 (2017).
pubmed: 28228547 pmcid: 5391182 doi: 10.1091/mbc.e15-04-0218
Mizoguchi, T., Ikeda, S., Watanabe, S., Sugawara, M. & Itoh, M. Mib1 contributes to persistent directional cell migration by regulating the Ctnnd1-Rac1 pathway. Proc. Natl. Acad. Sci. USA 114, E9280–E9289 (2017).
pubmed: 29078376 doi: 10.1073/pnas.1712560114
Matsushima, K., Tokuraku, K., Hasan, M. R. & Kotani, S. Microtubule-associated protein 4 binds to actin filaments and modulates their properties. J. Biochem. (Tokyo) 151, 99–108 (2012).
doi: 10.1093/jb/mvr119
Werner, E., Kowalczyk, A. P. & Faundez, V. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J. Biol. Chem. 281, 23227–23236 (2006).
pubmed: 16762926 doi: 10.1074/jbc.M603676200
Garlick, K. M. & Mogridge, J. Direct interaction between anthrax toxin receptor 1 and the actin cytoskeleton. Biochemistry 48, 10577–10581 (2009).
pubmed: 19817382 pmcid: 2847348 doi: 10.1021/bi9015296
Sharma, V. P. et al. Tks5 and SHIP2 regulate invadopodium maturation, but not initiation, in breast carcinoma cells. Curr. Biol. CB 23, 2079–2089 (2013).
pubmed: 24206842 doi: 10.1016/j.cub.2013.08.044 pmcid: 24206842
Oikawa, T. et al. Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell–cell fusion. J. Cell Biol. 197, 553–568 (2012).
pubmed: 22584907 pmcid: 3352951 doi: 10.1083/jcb.201111116
Kuo, J.-C., Han, X., Hsiao, C.-T., Yates, J. R. & Waterman, C. M. Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation. Nat. Cell Biol. 13, 383–393 (2011).
pubmed: 21423176 pmcid: 3279191 doi: 10.1038/ncb2216
Kim, D. I. et al. Probing nuclear pore complex architecture with proximity-dependent biotinylation. Proc. Natl. Acad. Sci. USA 111, E2453–2461 (2014).
pubmed: 24927568 doi: 10.1073/pnas.1406459111
Attanasio, F. et al. Novel invadopodia components revealed by differential proteomic analysis. Eur. J. Cell Biol. 90, 115–127 (2011).
pubmed: 20609496 doi: 10.1016/j.ejcb.2010.05.004
Cervero, P., Himmel, M., Krüger, M. & Linder, S. Proteomic analysis of podosome fractions from macrophages reveals similarities to spreading initiation centres. Eur. J. Cell Biol. 91, 908–922 (2012).
pubmed: 22721921 doi: 10.1016/j.ejcb.2012.05.005
Ezzoukhry, Z. et al. Combining laser capture microdissection and proteomics reveals an active translation machinery controlling invadosome formation. Nat. Commun. 9, 2031 (2018).
pubmed: 29795195 pmcid: 5966458 doi: 10.1038/s41467-018-04461-9
Branon, T. C. et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol. 36, 880–887 (2018).
pubmed: 30125270 pmcid: 6126969 doi: 10.1038/nbt.4201
Kim, D. I. et al. An improved smaller biotin ligase for BioID proximity labeling. Mol. Biol. Cell 27, 1188–1196 (2016).
pubmed: 26912792 pmcid: 4831873 doi: 10.1091/mbc.E15-12-0844
Di Martino, J. et al. The microenvironment controls invadosome plasticity. J. Cell Sci. 129, 1759–1768 (2016).
pubmed: 27029343 doi: 10.1242/jcs.182329
Juin, A. et al. Physiological type I collagen organization induces the formation of a novel class of linear invadosomes. Mol. Biol. Cell 23, 297–309 (2012).
pubmed: 22114353 pmcid: 3258174 doi: 10.1091/mbc.e11-07-0594
Lam, S. S. et al. Directed evolution of APEX2 for electron microscopy and proximity labeling. Nat. Methods 12, 51–54 (2015).
pubmed: 25419960 doi: 10.1038/nmeth.3179
Brudvig, J. J. et al. MARCKS Is Necessary for Netrin-DCC Signaling and Corpus Callosum Formation. Mol. Neurobiol. 55, 8388–8402 (2018).
pubmed: 29546593 pmcid: 6139093 doi: 10.1007/s12035-018-0990-3
Dingar, D. et al. BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. J. Proteomics 118, 95–111 (2015).
pubmed: 25452129 doi: 10.1016/j.jprot.2014.09.029
Uezu, A. et al. Identification of an elaborate complex mediating postsynaptic inhibition. Science 353, 1123–1129 (2016).
pubmed: 27609886 pmcid: 5432043 doi: 10.1126/science.aag0821
Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850–858 (1996).
doi: 10.1021/ac950914h
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
pubmed: 19029910 pmcid: 19029910 doi: 10.1038/nbt.1511
Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics MCP 13, 2513–2526 (2014).
pubmed: 24942700 doi: 10.1074/mcp.M113.031591
Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794–1805 (2011).
pubmed: 21254760 pmcid: 21254760 doi: 10.1021/pr101065j
Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116–5121 (2001).
pubmed: 11309499 doi: 10.1073/pnas.091062498
Deutsch, E. W. et al. The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition. Nucleic Acids Res. 45, D1100–D1106 (2017).
pubmed: 27924013 doi: 10.1093/nar/gkw936
Vizcaíno, J. A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223–226 (2014).
pubmed: 24727771 pmcid: 3986813 doi: 10.1038/nbt.2839
Mi, H., Muruganujan, A., Ebert, D., Huang, X. & Thomas, P. D. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 47, D419–D426 (2019).
Mi, H. et al. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat. Protoc. 14, 703–721 (2019).
pubmed: 30804569 pmcid: 6519457 doi: 10.1038/s41596-019-0128-8
Supek, F., Bošnjak, M., Škunca, N. & Šmuc, T. REVIGO summarizes and visualizes long lists of gene ontology terms. PloS One 6, e21800 (2011).
pubmed: 21789182 pmcid: 3138752 doi: 10.1371/journal.pone.0021800
von Mering, C. et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 33, D433–437 (2005).
doi: 10.1093/nar/gki005
Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607–D613 (2019).
pubmed: 30476243 doi: 10.1093/nar/gky1131

Auteurs

Sylvie Thuault (S)

Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Univ, INSERM, Institut Paoli-Calmettes, CNRS, Marseille, France. sylvie.thuault@inserm.fr.

Claire Mamelonet (C)

Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Univ, INSERM, Institut Paoli-Calmettes, CNRS, Marseille, France.

Joëlle Salameh (J)

Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Univ, INSERM, Institut Paoli-Calmettes, CNRS, Marseille, France.
INSERM UMR-S 1193, Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.

Kevin Ostacolo (K)

Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Univ, INSERM, Institut Paoli-Calmettes, CNRS, Marseille, France.
Department of Biochemistry and Molecular Biology, Biomedical Center, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Brice Chanez (B)

Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Univ, INSERM, Institut Paoli-Calmettes, CNRS, Marseille, France.
Institut Paoli-Calmettes, Department of Medical Oncology, Marseille, France.

Danièle Salaün (D)

Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Univ, INSERM, Institut Paoli-Calmettes, CNRS, Marseille, France.

Emilie Baudelet (E)

CRCM, Marseille Proteomics, Aix-Marseille Univ, INSERM, CNRS, Institut Paoli-Calmettes, Marseille, France.

Stéphane Audebert (S)

CRCM, Marseille Proteomics, Aix-Marseille Univ, INSERM, CNRS, Institut Paoli-Calmettes, Marseille, France.

Luc Camoin (L)

CRCM, Marseille Proteomics, Aix-Marseille Univ, INSERM, CNRS, Institut Paoli-Calmettes, Marseille, France.

Ali Badache (A)

Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Univ, INSERM, Institut Paoli-Calmettes, CNRS, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH